Sanofi | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 314.02B 34.8B 2024-12
Amgen USD 140.1B 33.03B 2024-12
AstraZeneca GBP 162.31B 17.34B 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Corcept Therapeutics USD 5.28B 444M 2024-12
Drreddys Laboratories USD 13.43B 639M 2024-09
Eli Lilly USD 732.87B 109.15B 2024-12
Galapagos EUR 1.76B 51.29M 2024-12
Genmab DKK 98.78B 8.42B 2024-12
GlaxoSmithKline GBP 55.81B 7.05B 2024-12
Glaxosmithkline USD 82.81B 2.66B 2024-09
Indivior 1.28B 325.08M 2024-12
J&J USD 348.19B 41.93B 2024-12
Merck USD 251.65B 36.21B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Novartis USD 230.87B 3.48B 2024-09
Pacira USD 870M 176M 2024-12
Perrigo USD 3.51B 70M 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Prestige Brands USD 3.86B 285M 2024-12
Sanofi EUR 118.41B 10.58B 2024-12
Sanofi USD 145.36B 23.34B 2024-09
Supernus Pharmaceuticals USD 2B 279M 2024-12
Zoetis USD 73.51B 15.01B 2024-12



Sanofi Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.